Florbetaben F-18
- Generic Name
- Florbetaben F-18
- Brand Names
- Neuraceq
- Drug Type
- Small Molecule
- Chemical Formula
- C21H26FNO3
- CAS Number
- 902143-01-5
- Unique Ingredient Identifier
- TLA7312TOI
- Background
Florbetaben is a fluorine-18 (18F)-labeled stilbene derivative used for Positron Emission Tomography (PET) imaging of the brain. It is used for the non-invasive detection of the density of ß-amyloid neuritic plaques in the brain of adult patients with cognitive impairment.
- Indication
Florbetaben is a radioactive diagnostic agent indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline.
- Associated Conditions
- Alzheimer's Disease (AD), Cognitive Deficits
- Associated Therapies
- -
Florbetaben PET Imaging in PPA
- Conditions
- Interventions
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2024-10-16
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 1
- Registration Number
- NCT04720001
- Locations
- 🇺🇸
University of Chicago - American School Building, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.